Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Kelly

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Medical Journal of Australia|September 24, 1999
What is the cause of a rash after measles-mumps-rubella vaccination?G A Jenkin, D Chibo, H A Kelly, et al.
The Medical Journal of Australia|July 1, 1996
A cluster of murine typhus cases in Western AustraliaL F O'Connor, H A Kelly, J M Lubich, et al.
Communicable Diseases Intelligence Quarterly Report|October 13, 2001
Measles immunity among young adults in VictoriaH A Kelly, M A Riddell, S B Lambert, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|April 29, 1998
The immunological response of llamas (Lama glama) following experimental infection with Mycobacterium bovisJ B Stevens, C O Thoen, E B Rohonczy, et al.
Communicable Diseases Intelligence|May 14, 1999
Australia's last reported case of wild poliovirus infectionM L Kennett, K A Brussen, D J Wood, et al.
Epidemiology and Infection|June 11, 2004
Mumps and rubella: a year of enhanced surveillance and laboratory testingR J Guy, R M Andrews, H A Kelly, et al.
Epidemiology and Infection|April 21, 2007
ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged > or = 65 yearsS A Skull, R M Andrews, G B Byrnes, et al.
Epidemiology and Infection|June 19, 2008
Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort studyS A Skull, R M Andrews, G B Byrnes, et al.
Journal of Epidemiology and Global Health|January 31, 2016
Verification of measles elimination in Australia: Application of World Health Organization regional guidelinesH F Gidding, N V Martin, V Stambos, et al.
Journal of Medicinal Chemistry|November 11, 1994
Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agentC D Eldred, B Evans, S Hindley, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Medical Journal of Australia|September 24, 1999
What is the cause of a rash after measles-mumps-rubella vaccination?G A Jenkin, D Chibo, H A Kelly, et al.
The Medical Journal of Australia|July 1, 1996
A cluster of murine typhus cases in Western AustraliaL F O'Connor, H A Kelly, J M Lubich, et al.
Communicable Diseases Intelligence Quarterly Report|October 13, 2001
Measles immunity among young adults in VictoriaH A Kelly, M A Riddell, S B Lambert, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|April 29, 1998
The immunological response of llamas (Lama glama) following experimental infection with Mycobacterium bovisJ B Stevens, C O Thoen, E B Rohonczy, et al.
Communicable Diseases Intelligence|May 14, 1999
Australia's last reported case of wild poliovirus infectionM L Kennett, K A Brussen, D J Wood, et al.
Epidemiology and Infection|June 11, 2004
Mumps and rubella: a year of enhanced surveillance and laboratory testingR J Guy, R M Andrews, H A Kelly, et al.
Epidemiology and Infection|April 21, 2007
ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged > or = 65 yearsS A Skull, R M Andrews, G B Byrnes, et al.
Epidemiology and Infection|June 19, 2008
Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort studyS A Skull, R M Andrews, G B Byrnes, et al.
Journal of Epidemiology and Global Health|January 31, 2016
Verification of measles elimination in Australia: Application of World Health Organization regional guidelinesH F Gidding, N V Martin, V Stambos, et al.
Journal of Medicinal Chemistry|November 11, 1994
Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agentC D Eldred, B Evans, S Hindley, et al.
Pageof 5